Geriatric Medication

Ageing increases the risk of chronic diseases such as diabetes, cardiac disorders, arthritis, and respiratory disorders that require continuous monitoring. Also, ageing decreases bone density that makes it a challenge for the geriatric population to continuously manage their medical needs and perform their daily activities. The global geriatric medicine market was valued at nearly USD 540 billion in 2015. One of the key factors attributing to its rapid growth includes rapidly increasing geriatric population base. According to the estimates published by the United Nations in 2012, the global geriatric population was estimated to be nearly 809.4 million, and is anticipated to reach nearly 1.13 billion by 2022 and exceed a value of over 2 billion by 2050. Furthermore, the rising prevalence of various target diseases, decreasing immunity levels, and the significant improvements in the healthcare systems across the globe are also significantly driving the market growth. Geriatric medication is concerned with the diagnosis, treatment and prevention of disease in older people and the problems specific to aging. The principle point of Geriatric Medicine is to give the most elevated quality clinical care to enhance the soundness of more established grown-ups and society by making, deciphering, and dispersing learning through instruction and research. It is a specialty that focuses on health care of elderly people. Follow Geriatrics Conferences to know more updates.

  • Geriatric Internal Medicine
  • Geriatric Emergency Medicine
  • Alternative Medicine and Anti-Ageing Drugs
  • Antipsychotic Medications
  • Iatrogenesis and Medication Optimization
  • Polypharmacy and Medication Errors

Related Conference of Geriatric Medication

Geriatric Medication Conference Speakers